Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Exacerbation of depression associated with starting raltegravir: a report of four cases.

Harris M, Larsen G, Montaner JS.

AIDS. 2008 Sep 12;22(14):1890-2. doi: 10.1097/QAD.0b013e32830e0169. No abstract available.

PMID:
18753871
2.

Severe rhabdomyolysis associated with raltegravir use.

Zembower TR, Gerzenshtein L, Coleman K, Palella FJ Jr.

AIDS. 2008 Jul 11;22(11):1382-4. doi: 10.1097/QAD.0b013e328303be40. No abstract available.

PMID:
18580624
3.

A case of rhabdomiolysis associated with raltegravir use.

Dori L, Buonomini AR, Viscione M, Sarmati L, Andreoni M.

AIDS. 2010 Jan 28;24(3):473-5. doi: 10.1097/QAD.0b013e328334cc4a. No abstract available.

PMID:
20087078
4.

Raltegravir, an HIV-1 integrase inhibitor for HIV infection.

Cabrera C.

Curr Opin Investig Drugs. 2008 Aug;9(8):885-98. Review.

PMID:
18666037
5.

[Integrase inhibitor: raltegravir also as first line therapy].

[No authors listed]

MMW Fortschr Med. 2010 Apr 29;152(17):48. German. No abstract available.

PMID:
20509261
6.

Treatment of HIV infection with raltegravir.

Chirch LM, Morrison S, Steigbigel RT.

Expert Opin Pharmacother. 2009 May;10(7):1203-11. doi: 10.1517/14656560902911488 . Review.

PMID:
19385721
7.

Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature.

Croce F, Vitello P, Dalla Pria A, Riva A, Galli M, Antinori S.

Int J STD AIDS. 2010 Nov;21(11):783-5. doi: 10.1258/ijsa.2010.010246.

PMID:
21187364
8.

FDA notifications. Raltegravir indication extended for treatment-naive patients.

[No authors listed]

AIDS Alert. 2009 Aug;24(8):93. No abstract available.

PMID:
19705587
9.

Effect of low-, moderate-, and high-fat meals on raltegravir pharmacokinetics.

Brainard DM, Friedman EJ, Jin B, Breidinger SA, Tillan MD, Wenning LA, Stone JA, Chodakewitz JA, Wagner JA, Iwamoto M.

J Clin Pharmacol. 2011 Mar;51(3):422-7. doi: 10.1177/0091270010367652. Epub 2010 May 10. No abstract available.

PMID:
20457591
10.

Anti-HIV agents. Integrase inhibitor raltegravir makes its mark.

[No authors listed]

TreatmentUpdate. 2007 Feb;19(2):8-9. No abstract available.

PMID:
17447316
11.

Raltegravir, a new HIV integrase inhibitor.

Gandhi RT.

AIDS Clin Care. 2007 Dec;19(12):105.

PMID:
18399003
12.

Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review.

Gray J, Young B.

AIDS Patient Care STDS. 2009 Sep;23(9):689-90. doi: 10.1089/apc.2009.0012. Review. No abstract available.

PMID:
19663717
13.

[Efficacy of raltegravir: from healthy volunteers to phase III trials].

Gatell JM.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:29-33. Review. Spanish.

PMID:
19572423
14.

Anti-HIV agents. Raltegravir (Isentress)--results after one year.

[No authors listed]

TreatmentUpdate. 2007 Sep-Oct;19(6):8-9. No abstract available.

PMID:
18041152
15.

Anti-HIV agents. Raltegravir--other issues.

[No authors listed]

TreatmentUpdate. 2007 Feb;19(2):9-10. No abstract available.

PMID:
17447317
16.

Isentress gets another good grade.

Dalton P.

Proj Inf Perspect. 2008 Sep;(46):9. No abstract available.

PMID:
19043877
17.

Study supports use of Isentress for first line treatment.

[No authors listed]

Proj Inf Perspect. 2008 Dec;(47):9. No abstract available.

PMID:
19227560
18.

[Integrase inhibition--a new mode of action in HIV therapy].

van Lunzen J, Degen O.

MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:64-7. German. No abstract available.

PMID:
19031567
19.

[Raltegravir: initially as effective as standard therapy].

Warpakowski A.

MMW Fortschr Med. 2010 Apr 29;152(17):49. German. No abstract available.

PMID:
20509262
20.

[Integrase inhibition].

Bogner JR.

MMW Fortschr Med. 2009 Apr 30;151(18):68-71. German. No abstract available.

PMID:
19769082

Supplemental Content

Support Center